Frontlight ResearchEarly access
Trial site
Istituto Nazionale dei Tumori,
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer3 trials
- Hodgkin lymphoma2 trials
- Ovarian cancer2 trials
- Cervical cancer1 trial
- Childhood cancers1 trial
- Follicular lymphoma1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Mesothelioma1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 37 trials
- Phase 23 trials
- Phase 11 trial
- Phase 2/31 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Not yet recruiting2 trials
- Lead sponsor
- AstraZeneca3 trials
- AstraZeneca AB2 trials
- Alessandro Ghelardi1 trial
- Celgene1 trial
- Inhibrx Biosciences Inc.1 trial
- and 4 more
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Not yet recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
- Mesothelioma1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Not yet recruiting
Active, not recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026